Glyceraldehyde-3-phosphate dehydrogenase pseudogene 66 (GAPDHP66)

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 66 (GAPDHP66) is a human genomic sequence classified as a pseudogene[1][3][4]. Pseudogenes are noncoding copies or fragments of functional genes, typically formed through gene duplication or retrotransposition, but rendered incapable of producing a functional protein due to disabling sequence changes[2]. While many pseudogenes are transcriptionally silent, some can influence cellular biology via noncoding RNA mechanisms such as acting as microRNA sponges, generating regulatory transcripts, or modulating stability and translation of cognate mRNAs[2]. However, for GAPDHP66, specific evidence of biological function, disease association, or utility as a biomarker or drug target is lacking[1][2][3][4].\nIn summary, GAPDHP66 does not meet criteria for a therapeutic target, does not encode protein, and lacks drug interactions or disease relevance. The gene is best described as a member of the pseudogene family, related to the glyceraldehyde-3-phosphate dehydrogenase gene family but functionally inert in terms of protein coding[1][3][4].

Other names

GAPDHL11GAPDL11glyceraldehyde-3-phosphate dehydrogenase-like 11

null